Efficacy of Tapinarof Cream 1% Once Daily in Patients With Moderate to Severe Atopic Dermatitis Aged 2 Years and Older
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Tapinarof Cream 1% Once Daily: Significant Efficacy in the Treatment of Moderate to Severe Atopic Dermatitis in Adults and Children Down to 2 Years of Age in the Pivotal Phase 3 ADORING Trials
J Am Acad Dermatol 2024 May 20;[EPub Ahead of Print], JI Silverberg, LF Eichenfield, AA Hebert, EL Simpson, L Stein Gold, R Bissonnette, KA Papp, J Browning, P Kwong, NJ Korman, PM Brown, DS Rubenstein, SC Piscitelli, MC Somerville, AM Tallman, L KircikFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.